Design Therapeutics (DSGN) Non Operating Income (2020 - 2026)

Design Therapeutics' Non Operating Income history runs 7 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 5.35% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $9.6 million (down 0.6% YoY), while the FY2025 annual figure was $9.7 million, up 4.57% from the prior year.
• Non Operating Income came in at $2.4 million for Q1 2026 at Design Therapeutics, up from $2.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $5.7 million in Q4 2023 to a low of $105000.0 in Q1 2022.
• A 5-year average of $2.4 million and a median of $2.4 million in 2023 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income jumped 7731.58% in 2022 and tumbled 53.43% in 2024, its largest moves.
• Design Therapeutics' Non Operating Income stood at $2.1 million in 2022, then soared by 175.93% to $5.7 million in 2023, then sank by 53.43% to $2.6 million in 2024, then decreased by 17.1% to $2.2 million in 2025, then gained by 10.02% to $2.4 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $2.4 million, $2.2 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison